Clinical Trial

Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
A Study to Investigate the Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia with or without Astigmatism by Transepithelial Photorefractive Keratectomy
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-09-26; most recent amendment 2025-06-13.
Trial Details
NCT Number NCT06618547
Lead Sponsor Bausch & Lomb Incorporated
Conditions Myopia
Enrollment 140 participants
Start Date 2025-11
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-06-15